Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Furuse

Showing results (101-110 of 348) with videos related to

Pageof 35
Sort By:
Anticancer Research|February 29, 2024
A Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer Refractory to Gemcitabine MonotherapyMariko Nishioka, Naohiro Okano, Masashi Wakabayashi, et al.
Japanese Journal of Clinical Oncology|December 28, 2018
Randomized phase III trial of post-operative chemotherapy for patients with stage I/II/III small bowel adenocarcinoma (JCOG1502C, J-BALLAD)Hideaki Kitahara, Yoshitaka Honma, Makoto Ueno, et al.
Cancer Science|August 14, 2014
Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancerTakuji Okusaka, Masafumi Ikeda, Akira Fukutomi, et al.
Annals of Surgical Oncology|February 1, 2008
Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapyMelanie B Thomas, James P O'Beirne, Junji Furuse, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2016
Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancerHideki Ueno, Masafumi Ikeda, Makoto Ueno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2010
[A case of mucosa-associated lymphoid tissue lymphoma with penicillin allergy successfully treated with levofloxacin, minomycin and rabeprazole]Tomoko Konno, Shigeatsu Motoori, Nozomi Iwamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 17, 2010
Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version)Masatoshi Kudo, Shouji Kubo, Kenichi Takayasu, et al.
British Journal of Cancer|May 5, 2017
Efficacy and safety of gemcitabine plus S-1 in pancreatic cancer: a pooled analysis of individual patient dataChikuma Hamada, Takuji Okusaka, Takaaki Ikari, et al.
Pancreas|March 6, 2020
Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A SynopsisTakuji Okusaka, Masafumi Nakamura, Masahiro Yoshida, et al.
Japanese Journal of Clinical Oncology|October 18, 2012
Clinical outcome of biliary drainage for obstructive jaundice caused by colorectal and gastric cancersAkiyoshi Kasuga, Hiroshi Ishii, Masato Ozaka, et al.
Pageof 35

Showing results (101-110 of 348) with videos related to

Sort By:
Pageof 35
Anticancer Research|February 29, 2024
A Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer Refractory to Gemcitabine MonotherapyMariko Nishioka, Naohiro Okano, Masashi Wakabayashi, et al.
Japanese Journal of Clinical Oncology|December 28, 2018
Randomized phase III trial of post-operative chemotherapy for patients with stage I/II/III small bowel adenocarcinoma (JCOG1502C, J-BALLAD)Hideaki Kitahara, Yoshitaka Honma, Makoto Ueno, et al.
Cancer Science|August 14, 2014
Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancerTakuji Okusaka, Masafumi Ikeda, Akira Fukutomi, et al.
Annals of Surgical Oncology|February 1, 2008
Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapyMelanie B Thomas, James P O'Beirne, Junji Furuse, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2016
Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancerHideki Ueno, Masafumi Ikeda, Makoto Ueno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2010
[A case of mucosa-associated lymphoid tissue lymphoma with penicillin allergy successfully treated with levofloxacin, minomycin and rabeprazole]Tomoko Konno, Shigeatsu Motoori, Nozomi Iwamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 17, 2010
Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version)Masatoshi Kudo, Shouji Kubo, Kenichi Takayasu, et al.
British Journal of Cancer|May 5, 2017
Efficacy and safety of gemcitabine plus S-1 in pancreatic cancer: a pooled analysis of individual patient dataChikuma Hamada, Takuji Okusaka, Takaaki Ikari, et al.
Pancreas|March 6, 2020
Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A SynopsisTakuji Okusaka, Masafumi Nakamura, Masahiro Yoshida, et al.
Japanese Journal of Clinical Oncology|October 18, 2012
Clinical outcome of biliary drainage for obstructive jaundice caused by colorectal and gastric cancersAkiyoshi Kasuga, Hiroshi Ishii, Masato Ozaka, et al.
Pageof 35